CLINICAL_TRIALS
trial_result
· 2018-10-09
Clinical Trial Update: A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants [Phase 1]
Summary
Phase 1 clinical trial studying Evacetrapib in participants with severe renal impairment and in healthy participants; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED | Results posted: 2018-10-09